Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602471 · ClinicalTrials.gov registry record · Phase 2
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
A Phase 2 study, sponsored by Siemens Molecular Imaging.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT01602471: Clinical Trial Phase 2 study, sponsored by Siemens Molecular Imaging.
NCT01602471 is a Phase 2 study that was terminated before completion, run by Siemens Molecular Imaging. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01602471, a Phase 2 study, was terminated before completion, sponsored by Siemens Molecular Imaging.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
This trial will be the first trial for the Investigation Product (IP), \[F-18\]RGD-K5 for carotid plaque imaging and will be conducted as a Phase II trial since this compound has already been tested in humans for phase I and phase II imaging. All study results will be evaluated and analyzed in order to consider the design for future clinical trials.
Primary Outcome
Based on the small sample size and lack of IHC analyses, no efficacy conclusions can be drawn from this study.
Interventions
- DRUG [F-18]RDG-K5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Why NCT01602471 stopped before completion
NCT01602471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which [F-18]RDG-K5 is the first listed.
NCT01602471 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01602471 about?
NCT01602471 is a clinical study titled "[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis". This trial will be the first trial for the Investigation Product (IP), \[F-18\]RGD-K5 for carotid plaque imaging and will be conducted as a Phase II trial since this compound has already been tested in humans for phase I and phase II imaging. All study results will be evaluated and analyzed in order...
What is the current status of trial NCT01602471?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2012-05. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01602471?
The interventions under investigation include: [F-18]RDG-K5 (DRUG).
Who is sponsoring clinical trial NCT01602471?
This trial is sponsored by Siemens Molecular Imaging, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01602471's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia